The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q3 2022 call → NOWe need to determine if management conveys that the reported results for the period (Q3 2022) do not represent the business as it is actually running today. The call is from November 14, 2022, discussing Q3 2022 results. The company is Cue Biopharma, a biotech with clinical trials. The reported period likely has no revenue (or minimal collaboration revenue) and R&D expenses. The business is about clinical development. Management discusses data from trials, recent SITC presentation, combination trial results, CUE-102 first patient treated, etc. They emphasize that the data from CUE-101 and combination are recent and represent progress. They also mention a $30 million PIPE financing to extend runway into 2024. The question: does management convey that the reported period's numbers are stale relative to the operating present? The reported period is Q3 2022 (ended Sept 30, 2022). The call is in November 2022. They discuss data presented at SITC (which was likely in November 2022, just before the call). They also mention treating first patient with CUE-102. They talk about recent data and milestones. However, the financial results are just cash, expenses. The business is clinical development, so the "business" is the pipeline progress. Management is highlighting that since the period ended, they have new data, new patient, etc. But is that a gap? They are not saying the reported numbers don't reflect the business; they are providing updates on clinical progress that happened after the quarter. The question asks if management conveys that the reported results do not represent the business they are actually running today. In biotech, the reported period is just financials; the business is the pipeline. Management often discusses recent developments. But the key is whether they explicitly or implicitly say the period is stale. They might say "we have made significant progress since the quarter end" but that's typical. The instruction says: "Answer YES when management's own words convey... the printed period is stale relative to the operating present." Examples include: meaningful business began late in period or just after; pace of business currently sits above period's figures; period carried costs of things whose benefits have only just begun; pointing to what company has already become.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.